WEST LAFAYETTE, Ind., July 3, 2012 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that Mike Sherman, chief financial officer for Endocyte, will present at the JMP Securities 7th Annual Healthcare Conference on Friday, July 13, at noon EDT. The conference is being held at the Peninsula New York.
